Scale-up– tag –
-
Cultivated Meat Faces Scientific, Sustainability, and Regulatory Hurdles: Microcarriers and Biomanufacturing Process Improvements are Critical
ResearchGate Unknown Overview A recent review highlights the major scientific, sustainability, and regulatory challenges confronting the cultivated meat industry. The study emphasizes the pivotal role of microcarriers as a key enabling t... -
CellFiber and Tidewave Bio Partner to Advance Next-Generation Solid Tumor Immunotherapy Manufacturing Scale-Up via 3D Cell Culture Platform
(Biotech News) Japan Overview CellFiber and Tidewave Bio announced a strategic collaboration to evaluate CellFiber's 3D cell culture platform for the scalable manufacturing of Tidewave's next-generation cell immunotherapy. This proof-of-... -
Japan’s Healios K.K. Establishes Commercial Manufacturing System: 500L Bioreactor Operational with Minaris, Targeting 40,000 Patient Doses Annually
Healios K.K. Japan Overview Japan's Healios K.K., in its Q2 FY2026 financial results, announced the establishment of a commercial manufacturing system with Minaris and the completion of full-scale production using 50L bioreactors. Engine... -
NueCell Bio Unveils 26,300 Sq Ft Cell Therapy Development Facility in San Diego, Bolstering Clinical & Commercial Manufacturing
PharmaSource USA Overview NueCell Bio has officially opened its 26,300-square-foot cell therapy development facility in San Diego, significantly enhancing its clinical and commercial manufacturing capabilities. The state-of-the-art facil... -
CGT Patient Access Hinges on Manufacturing and Logistics Strategy, Alongside Bridging Public Communication Gaps
BioProcess International USA Overview Cell Summit 2026 highlighted critical strategies for improving patient access to cell and gene therapies (CGTs), emphasizing the shift towards localized capabilities, enhanced hospital readiness, and... -
Liv Hospital Advances iPSC Reprogramming, Sets Sights on Scalable Production for Regenerative Medicine
Liv Hospital Turkey Overview Liv Hospital's latest research details critical optimizations in induced pluripotent stem cell (iPSC) reprogramming, emphasizing advanced gene delivery systems and optimal vector selection for efficient and s... -
Miltenyi Biotec’s CliniMACS Prodigy® Automates TIL Expansion, Paving Way for Scalable Cancer Immunotherapy
Bioprocess Online Germany Overview Miltenyi Biotec is advancing the automated expansion of tumor-infiltrating lymphocytes (TILs) using its GMP-compliant CliniMACS Prodigy® platform. This system addresses critical challenges in scaling up... -
Scaling the Future of Medicine: RoosterBio and Applied StemCell Partner on iPSC Bioprocess Solutions
PRNewswire USA Overview RoosterBio and Applied StemCell have announced a strategic partnership aimed at advancing scalable induced pluripotent stem cell (iPSC)-based bioprocess solutions. This collaboration integrates Applied StemCell's ... -
CDMOs Accelerate GLP-1 Manufacturing, Outpacing Traditional Facility Builds to Meet Soaring Demand
Pharma Advancement USA Overview Contract Development and Manufacturing Organizations (CDMOs) are rapidly scaling their manufacturing capabilities for GLP-1 receptor agonists, providing quicker solutions than ground-up facility constructi... -
Cerebral Organoids Enter Industrial Era: Automation Drives Standardization and High-Throughput Scaling for Neuroscience Innovation
Newfund Capital USA Overview Cerebral organoid production is undergoing a transformative industrialization, driven by automated platforms for iPSC generation, expansion, and differentiation. This technological leap standardizes manufactu...
